Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real World Study of the Treatment of Locally-inoperable Advanced or Advanced Metastatic Gastric Adenocarcinoma With Huachansu

NCT05249244 is registered in ClinicalTrials.gov with China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT05249244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05249244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real World Study of the Treatment of Locally-inoperable Advanced or Advanced Metastatic Gastric Adenocarcinoma With Huachansu
Lead sponsor
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2021
Completion date
February 28, 2022
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric adenocarcinoma